目的 设计、合成含有二氢吡唑杂环结构的黄酮类衍生物，并初步探讨其体外抗氧化活性。方法 以邻苯二酚为起始原料合成先导化合物7-羟基黄酮，与1，2-二溴乙烷反应得到7-溴乙氧基黄酮再经与含有邻羟基苯取代的二氢吡唑类化合物缩合得到6个含有二氢吡唑杂环结构的黄酮衍生物。目标化合物的结构通过IR、1H-NMR、13C-NMR、ESI-MS和元素分析进行确证。测定了目标化合物清除超氧自由基(O－·2)、羟自由基(·OH)、亚硝基自由基(NO2·)和2，2-二苯基-1-苦味酰基自由基(DPPH·)的活性及总还原能力。结果 在0.5 mg·mL-1时，多数目标化合物具有抗氧化活性，但均弱于对照维生素C的抗氧化作用。结论 7-(1-苯基-3-甲基-4，5-二氢吡唑-5-苯基)-氧乙氧基黄酮(化合物2a)对4种自由基的清除作用及其总还原能力均较强，可以进一步进行体内抗氧化活性研究。
Abstract
OBJECTIVE To design and synthesize flavone derivatives containing dihydropyrazole moiety and investigate their antioxidative activities in vitro. METHODS 7-Bromoethoxy flavone was synthesized by the reaction of 7-hydroxy flavone with 1,2-dibromoethane. Then six flavone derivatives containing dihydropyrazole moiety were synthesized by the condensation reaction of 7-bromoethoxy flavone with two types of O-phenyl substituted dihydropyrazole compounds. These new compounds were characterized by IR, 1H-NMR, 13C-NMR, ESI-MS and EA. Their antioxidation effects, such as scavenging effects on the superoxide radical (O－·2), hydroxyl radical (·OH), DPPH· radical, nitroso radicals (NO2·)and the total reduction activities, were compared. RESULTS At the concentration of 0.5 mg·mL-1 most of the title compounds had antioxidation effects, but their activities were weaker than that of vitamine C. CONCLUSION The scavenging effects on four different radicals and the total reduction activity of 7-(1-phenyl-3-methyl-4,5-dihydropyrazole-5-phenyl)-oxyethoxy flavone (compound 2a) are all relatively strong. Its antioxidative activities in vivo can be further investigated.
关键词
二氢吡唑 /
黄酮 /
合成 /
抗氧化
{{custom_keyword}} /
Key words
dihydropyrazole /
flavone /
synthesis /
antioxidation
{{custom_keyword}} /
中图分类号：
R914.5
{{custom_clc.code}}
({{custom_clc.text}})
{{custom_sec.title}}
{{custom_sec.title}}
{{custom_sec.content}}
参考文献
[1] YAN X, LIU H Q, ZOU Y Q, et al. Physiological activities and research advance in synthesis of flavonoids. Chin J Org Chem(有机化学), 2008, 28(9):1534-1544.
[2] HU K, YANG Z H, PAN S S, et al. Synthesis and anticancer activity of liquiritigenin thiosemicarbazone derivatives. Eur J Med Chem, 2010, 45(8):3453-3458.
[3] KUL E A, MAGAMBETOVA V I, YAMOVOI D D, et al. Synthesis and structure of pinosterobin oxime and its biological antivity. Chem Nat Compd, 2002, 38(6):527-531.
[4] ACHARYA B N, SARASWAT D, TIWARI M, et al. Synthesis and antimalarial evaluation of 1, 3, 5-trisubstituted pyrazolines. Eur J Med Chem, 2010, 45(2):430-438.
[5] SHAHARYAR M, ABDULLAH M M, BAKHT M A, et al. Pyrazoline bearing benzimidazoles:search for anticancer agent. Eur J Med Chem, 2010,45(1):114-119.
[6] PAN Y, CHEN Y C, LI Q N, et al. The synthesis and evaluation of novel hydroxyl substituted chalcone analogs with in vitro anti-free radicals pharmacological activity and in vivo anti-oxidation activity in a free radical-injury Alzheimer′s model. Molecules, 2013, 18(2):1693-1703.
[7] HAVRYLYUK D, ZIMENKOVSKY B, VASYLENKO O, et al. Synthesis of novel thiazolone-based compounds containing pyrazoline moiety and evaluation of their anticancer activity. Eur J Med Chem, 2009, 44(4):1396-1404.
[8] INSUASTY B, TIGREROS A, OROZCO F, et al. Synthesis of novel pyrazolic analogues of chalcones and their 3-aryl-4-(3-aryl-4,5-dihydro-1H-pyrazol-5-yl)-1-phenyl-1H-pyrazole derivatives as potential antitumor agents. Bioorg Med Chem, 2010, 18(14):4965-4974.
[9] DUAN Z F, FU L, LI C B. Syntheses and biological activities of 7-(substituted triazolo thioethoxy)flavone derivatives. Chem J Chin Univ (高等学校化学学报), 2015, 36(1):102-109.
ZHAO F, LIANG H, CHENG H, et al. Synthesis, characterization and antioxidative activity of metal complexes with rhein . Acta Chim Sin(化学学报), 2011, 69(8):925-930.
LI S H, WU X J, ZENG J Y. In vitro and in vivo antioxidant properties of the total flavonoids from lithocarpus polystachyus Rehd. Chin Pharm J(中国药学杂志), 2014, 49(9):731-735.
LIANG H, XIANG Z, MA T X, et al. Synthesis and antioxidant activities of novel chalcone FMC and its analogues. Chin Pharm J(中国药学杂志), 2014, 49(21):1939-1944.
{{custom_fnGroup.title_cn}}
脚注
{{custom_fn.content}}
基金
广东省教育厅重点平台与重大项目资助课题(2014KZDXM075)
{{custom_fund}}
PDF(752 KB)
